ACCESS REALMONEY
Winners & Losers
Thursday's Health Winners & Losers
05/01/08 - 02:58 PM EDT
- Article Tools
- Email this Article
- Print this Article
- Rss Feed
- Related Articles
- Wednesday's Health Winners & Losers
- Tuesday's Health Winners & Losers
- Monday's Health Winners & Losers
- Del.icio.us
- Digg
- StumbleUpon
Health stocks followed the broader markets into a refreshing green spell on Thursday amid medical technology and diagnostics earnings. Big biotechs Amgen AMGN and Biogen Idec BIIB were up trading up more than 2% each. Also Gilead GILD and Genzyme GENZ added 1.4% and 1.2% respectively. In fact, every stock on the Amex biotechnology index, which was up 2.1% at 760.94, read green midday Thursday except for biotech behemoth Genentech DNA. Its shares were incidentally off by 0.4%, at $67.92. Away from biotechs, Orthopedic product maker Orthofix International NV OFIX said Thursday that its first-quarter profit fell to $3.6 million, or 21 cents a share, from $6.3 million, or 37 cents a share, in the year-ago period. Revenue rose 9% to $128 million from $117 million, beating expectations of analysts polled by Thomson Financial who expected profit of 9 cents a share on revenue of $122.5 million. The beat prompted a 14.6% rise in the stock, to $35.25. Also up, Natus Medical BABY 6.5% to $20.94 after beating first-quarter earnings estimates and raising guidance. The newborn-care product maker said it earned $2.6 million, or 11 cents a share, up 73% from $1.5 million, and 7 cents a share, in the year-ago quarter. Revenue climbed 36% to $36.9 million, analysts surveyed by Thomson Financial were looking for 10 cents a share, on $35.5 million in revenue. Natus also upped its first-quarter expectations to 72 cents a share on revenue of $162 million, from previous guidance of 70 cents and $161 million.
BioMarin climbs higher after swinging to a profit and beating Wall Street estimates for the first quarter.
FDA rejection hits Merck shares.
Regulatory delays send Medarex to a new 52-week low.
Yahoo! is among the most searched stocks on TheStreet.com. Here's what Cramer had to say about the stock recently.
Catch up on his thinking on the hottest topics of the past week.
Investors will have to deal with a Fed meeting and another flood of earnings and economic data.
Ensco International and Echelon have the potential to move higher in coming days.
See who made what calls.
The addition of video is helping telecom companies compete against cable and satellite companies.
The June West Texas Intermediate contract reflects selling pressure ahead of Tuesday's expiration. But stocks in the sector are generally trading higher.
See who made what calls.
Keep on top of the market and the critical information you need to make more profitable investing decisions.
Sponsored by:
RSS
